Dexmedetomidine and Delirium in Elderly Patients
- Conditions
- Delirium, Dexmedetomidine, Postoperative PCA
- Interventions
- Drug: DexmedetomidineDrug: Fentanyl-based PCA infusion
- Registration Number
- NCT03938831
- Lead Sponsor
- Korea University Guro Hospital
- Brief Summary
Investigators investigates the effect of perioperative dexmedetomidine 0.5 ug/kg/hr followed by a postoperative continuous infusion fentanyl-based PCA(Patient-Controlled Analgesia) drug mixed with dexmedetomidine 0.2ug/kg/hr for two days on reducing postoperative delirium and postoperative rescue analgesics in elderly patients who undergo hip surgery. The other half of patients received fentanyl-based PCA only.
- Detailed Description
Elderly patients are susceptible to postoperative delirium. Delirium occurs in 10\~60% and is associated with longer hospital stays, increased costs, and morbidity. Postoperative delirium usually occurs 2\~3 days after surgery. Intraoperative infusion of dexmedetomidine lacks preventing postoperative delirium in elderly noncardiac major surgery.
We hypothesized postoperative dexmedetomidine for two days as a mixture drug of fentanyl-based PCA could reduce the incidence of postoperative delirium. We compared this effect with other control group who received fentanyl-based PCA only.
We also investigate EEG patterns of patients during emergence and compared the EEG patterns who developed delirium postoperatively in PACU(Postanesthesia care unit) or general ward. Dexmedetomidine has analgesic effect. We expected postoperative dexmedetomidine has benefits of opioid sparing effects.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
over 65 yrs old elderly patient who undergo elective hip surgery and ASA(The American Society of Anesthesiologists) physical status I-III
history of dementia, drug abuser, hypersensitivity to dexmedetomidine, fentanyl, propofol, disable to speech, reject the clinical study, hemodynamic instability during surgery, an illiterate, pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description dexmedetomidine group Fentanyl-based PCA infusion dexmedetomidine mixture with fentanyl-based PCA infusion for 2 days control group Fentanyl-based PCA infusion Fentanyl-based PCA infusion for 2 days dexmedetomidine group Dexmedetomidine dexmedetomidine mixture with fentanyl-based PCA infusion for 2 days
- Primary Outcome Measures
Name Time Method delirium 2 days reduction of incidence of delirium
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
KoreaUniversity Guro Hospital
🇰🇷Seoul, Guro-ku, Korea, Republic of